CSF biomarker variability in the Alzheimer's Association quality control program

…, LM Shaw, C Sisowath, A Skinningsrud… - Alzheimer's & …, 2013 - Wiley Online Library
Background The cerebrospinal fluid (CSF) biomarkers amyloid beta 1–42, total tau, and
phosphorylated tau are used increasingly for Alzheimer's disease (AD) research and patient …

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

…, J Schröder, LM Shaw, A Skinningsrud… - Alzheimer's & …, 2011 - Wiley Online Library
Background The cerebrospinal fluid (CSF) biomarkers amyloid β (Aβ)‐42, total‐tau (T‐tau),
and phosphorylated‐tau (P‐tau) demonstrate good diagnostic accuracy for Alzheimer's …

Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic

…, R Sanchez-Valle, A Ladogana, A Skinningsrud… - Molecular …, 2016 - Springer
At present, the testing of 14-3-3 protein in cerebrospinal fluid (CSF) is a standard biomarker
test in suspected sporadic Creutzfeldt-Jakob disease (sCJD) diagnosis. Increasing 14-3-3 …

Serum ferritin and transferrin saturation in patients with chronic alcoholic and non‐alcoholic liver diseases

H Bell, A Skinningsrud, N Raknerud… - Journal of internal …, 1994 - Wiley Online Library
Objectives. To compare serum ferritin concentration and transferrin saturation in patients with
alcoholic and non‐alcoholic chronic liver diseases. Design. Concecutive patients with liver …

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

…, T Pirttila, L Saleh, A Skinningsrud… - Annals of clinical …, 2009 - journals.sagepub.com
Background Different cerebrospinal fluid (CSF) amyloid-beta 1–42 (Aβ 1–42 ), total Tau (Tau)
and Tau phosphorylated at threonine 181 (P-Tau) levels are reported, but currently there is …

Mild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrity

…, A Bjørnerud, P Due-Tønnessen, A Skinningsrud… - Radiology, 2013 - pubs.rsna.org
Purpose To evaluate the relationship between (a) pathologic levels of cerebrospinal fluid (CSF)
total tau as an index of the intensity of ongoing neuronal degeneration and (b) …

[HTML][HTML] Cerebrospinal fluid markers in Creutzfeldt-Jakob disease

A Skinningsrud, V Stenset, AS Gundersen… - Cerebrospinal Fluid …, 2008 - Springer
Background The objective was to assess the utility of total tau protein (tTau), the ratio of (tTau)/181
phosphorylated tau protein (P-Tau) and 14-3-3 protein, as diagnostic markers in …

Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment

…, R Grambaite, A Skinningsrud… - American Journal …, 2008 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Mild cognitive impairment (MCI) may affect several cognitive
domains, including attention and reasoning, but is often first characterized by memory …

Associations between white matter lesions, cerebrovascular risk factors, and low CSF Aβ42

…, L Johnsen, D Kocot, A Negaard, A Skinningsrud… - Neurology, 2006 - AAN Enterprises
Objective: To analyze a putative relationship between white matter lesions (WMLs), risk factors
for WMLs, and Alzheimer disease (AD) as measured with the surrogate marker CSF Aβ42…

[HTML][HTML] Perinatal asphyxia may influence the level of beta-amyloid (1-42) in cerebrospinal fluid: an experimental study on newborn pigs

…, L Pankratov, R Solberg, N Bolstad, A Skinningsrud… - PLoS …, 2015 - journals.plos.org
Objective Total tau (T-tau), phosphorylated tau (p-Tau) and Beta-Amyloid 1–42 (AB42) in
Cerebrospinal Fluid (CSF) are useful biomarkers in neurodegenerative diseases. The aim of …